HuvePharma, a Bulgarian pharmaceutical company, reported on the results of its randomized, double-blind, placebo-controlled Phase2 clinical trial investigating its ivermectin-based product called Huvemek.® The sponsor…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.